Gene Transfer Technologies Market, By Type (Viral vectors, Non-viral vectors, Reagents, kits, and assays, and Instruments), By Application, By Technology, By Delivery Method, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5049
|
Published Date
April 2026
|
Pages
376
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Gene Transfer Technologies Market size was valued at US$ 4,361.72 Million in 2025, expanding at a CAGR of 9.09% from 2026 to 2033.
Gene transfer technologies refer to a set of biological and bioengineering methods used to introduce genetic material such as DNA or RNA into cells in order to modify, replace, or regulate gene function for therapeutic or research purposes. These techniques are widely applied in gene therapy, cell therapy, vaccine development, and advanced biomedical research to treat genetic disorders, cancer, and rare diseases. The process typically relies on viral or non-viral delivery systems to achieve targeted and efficient gene transfer into specific cells. This field is increasingly contributing to the advancement of precision medicine and next-generation treatment approaches in healthcare.
The gene transfer technologies sector is experiencing steady progress, supported by growing clinical adoption and evolving regulatory frameworks. According to the European Medicines Agency, several gene therapy products have been approved under the Advanced Therapy Medicinal Products (ATMP) framework, reflecting a structured approach to evaluating and providing access to innovative treatments across Europe. In addition, the UK Medicines and Healthcare products Regulatory Agency continues to support clinical trials for advanced therapy medicinal products through initiatives such as its Innovation Accelerator program, helping to accelerate the safe development of gene-based medicines.
Gene Transfer Technologies Market- Market Dynamics
Rising Focus on Genetic Medicine and Precision Healthcare
Growing awareness of genetic diseases and the need for targeted treatment approaches is driving the adoption of gene transfer technologies. Governments are increasingly investing in genomic research and precision medicine programs to improve healthcare outcomes. For example, the National Institutes of Health supports large-scale initiatives such as the All of Us Research Program, which aims to advance understanding of genetic variation in disease prevention and treatment. In Europe, the European Commission funds advanced research under the Horizon Europe program, including gene and cell therapy development. From an industry perspective, companies such as Novartis and Roche are actively developing gene-based therapies for rare diseases and cancer, reflecting strong alignment with precision medicine trends. This growing emphasis on personalized healthcare continues to support the adoption of gene transfer technologies in modern therapeutic development.
Gene Transfer Technologies Market- Segmentation Analysis:
The Global Gene Transfer Technologies Market is segmented on the basis of Type, Application, Technology, Delivery Method, End User, and Region.
Among the different types, viral vectors are expected to remain highly influential in gene transfer technologies due to their strong ability to efficiently deliver genetic material into target cells. These systems are widely used in gene therapy and cell therapy development because they enable precise delivery and stable gene expression. Companies such as Novartis, Bristol Myers Squibb, and Pfizer are actively leveraging viral vector platforms in therapies targeting genetic disorders and oncology applications. For instance, Novartis utilizes AAV-based viral vector technology in gene therapy approaches for rare neurological conditions, enabling the delivery of functional genes directly to affected cells. Similarly, Bristol Myers Squibb applies viral vector systems in CAR-T cell therapies to modify immune cells for cancer treatment. Their broad applicability and proven therapeutic effectiveness continue to support their widespread use across gene transfer applications.
From a technology perspective, CRISPR is expected to account for a significant share of the market due to its ability to precisely edit genetic material at specific locations. This technology is widely used in research and therapeutic development for genetic disorders, cancer, and rare diseases. Companies such as CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine are actively developing CRISPR-based treatments, with a focus on conditions such as sickle cell disease and other blood-related genetic disorders. For example, CRISPR Therapeutics has advanced gene-editing therapies designed to modify patient cells and restore normal gene function in inherited diseases. In parallel, pharmaceutical companies such as Novartis are collaborating in CRISPR-based programs to support the clinical development of gene-edited therapies. Its accuracy, flexibility, and ability to directly correct genetic defects continue to drive its growing adoption in advanced therapeutic development.
Gene Transfer Technologies Market- Geographical Insights
Growth in this market is observed across several regions, including North America, Europe, and parts of Asia, with each contributing through strong research capabilities, supportive regulatory frameworks, and increasing clinical adoption of gene-based therapies. Among these, North America—particularly the United States—is expected to hold a significant share due to well-defined regulatory systems, sustained public research funding, and active participation from biotechnology companies.
The U.S. Food and Drug Administration plays a central role in overseeing gene therapy products through its Center for Biologics Evaluation and Research (CBER), providing structured approval pathways such as Investigational New Drug (IND) applications and Biologics License Applications (BLA) that support safe clinical development. According to FDA records, more than 30 cell and gene therapy products have been approved, addressing rare genetic disorders, cancers, and inherited diseases. The FDA also issues detailed guidance on genome editing and manufacturing standards to enhance safety and consistency. In addition, the National Institutes of Health supports large-scale genomic research through institutes such as the National Human Genome Research Institute (NHGRI), strengthening scientific understanding of gene function and disease-related variations.
Within the region, the United States remains highly active in translating gene transfer research into clinical applications, supported by both government initiatives and industry participation. A key initiative is the Bespoke Gene Therapy Consortium, led by the NIH and FDA in collaboration with private partners, which aims to standardize development pathways for rare disease gene therapies and improve vector manufacturing efficiency. Companies such as Novartis, Pfizer, Bristol Myers Squibb, and CRISPR Therapeutics are actively advancing gene delivery platforms and approved therapies such as Zolgensma and Hemgenix, reflecting strong industry engagement within the U.S. healthcare ecosystem. This combination of regulatory structure, government-funded genomic research, and active commercial development continues to reinforce North America’s position as a leading hub for gene transfer technologies and precision medicine innovation.
China Gene Transfer Technologies Market- Country Insights
China is steadily advancing in the gene transfer technologies space, supported by strong national policy direction, expanding biotechnology capabilities, and increasing clinical research activity. The National Development and Reform Commission, under China’s 14th Five-Year Plan for Bioeconomy Development (2021–2025), identifies biotechnology as a strategic pillar industry, with a focus on gene editing, genetic diagnostics, and advanced therapeutic development. This reflects the government’s long-term commitment to innovation-driven healthcare growth.
In addition, the Ministry of Science and Technology of the People\'s Republic of China continues to support national research programs in precision medicine and genomic sciences, strengthening the scientific foundation for gene-based innovation. The National Medical Products Administration has also introduced structured regulatory pathways for cell and gene therapies, enabling controlled clinical trials and gradual approvals of advanced therapeutic products. Within China, companies such as Legend Biotech, WuXi AppTec, and Sino Biopharmaceutical are actively involved in gene-modified cell therapies, manufacturing support, and clinical collaborations. For example, Legend Biotech has contributed to CAR-T and gene therapy development programs in partnership with global pharmaceutical companies, reflecting China’s growing integration into advanced biomedical innovation networks.
Gene Transfer Technologies Market- Competitive Landscape:
Globally, the market is supported by a diverse network of biotechnology companies, pharmaceutical firms, and gene therapy specialists, all working to advance genetic-based treatment solutions in a more structured and effective manner. Key players such as Novartis, Roche, Pfizer, Bristol Myers Squibb, Sarepta Therapeutics, and CRISPR Therapeutics are actively focused on viral vector platforms, RNA delivery systems, and gene-editing technologies to address complex diseases. These companies differentiate themselves through improved delivery precision, enhanced safety profiles, and expanding clinical pipelines targeting rare and chronic conditions. For instance, Novartis continues to advance its AAV-based gene therapy programs for rare neurological disorders, reinforcing its focus on precision medicine development.
Market growth is further driven by strategic collaborations, increased research funding, and ongoing improvements in production and manufacturing capabilities. Companies such as Bluebird Bio, Amgen, and Takeda Pharmaceutical Company are strengthening scalable vector production and enhancing process reliability to support both clinical and commercial gene therapy development. Strategic partnerships with research institutions and contract development and manufacturing organizations (CDMOs) are also improving production consistency and accelerating innovation. The sector continues to evolve through advancements in gene delivery systems, expansion into broader therapeutic applications, and increasing collaboration across the ecosystem, supporting more targeted and personalized treatment approaches in modern healthcare.
Recent Developments:
- In November 2025, Eli Lilly and Company entered a strategic agreement with MeiraGTx to obtain worldwide exclusive rights to experimental gene therapy programs targeting inherited eye disorders. The agreement also includes access to riboswitch-based gene regulation technology, strengthening ophthalmology-focused gene therapy development and advancing precision medicine applications.
- In November 2025, AGC Biologics announced a manufacturing agreement with AAVantgarde Bio to support development and GMP production of dual-vector AAV gene therapies for inherited retinal disorders. This partnership enhances large-scale viral vector manufacturing capabilities for late-stage gene therapy programs.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis
- Roche (Spark Therapeutics)
- Pfizer
- Bristol Myers Squibb
- Sanofi
- Gilead Sciences (Kite Pharma)
- Bluebird Bio
- Sarepta Therapeutics
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Regenxbio
- Orchard Therapeutics
- BioMarin Pharmaceutical
- UniQure
- Sangamo Therapeutics
- Voyager Therapeutics
- Vertex Pharmaceuticals
- Alnylam Pharmaceuticals
- Amgen
- Takeda Pharmaceutical
- Lonza Group
- Thermo Fisher Scientific
- Danaher Corporation (Cytiva)
- Merck KGaA
- Sartorius AG
- Charles River Laboratories
- Qiagen
- Agilent Technologies
- Catalent
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Viral vectors
- Non-viral vectors
- Reagents, kits, and assays
- Instruments
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Gene therapy
- Cell therapy
- Vaccine development
- Research & drug discovery
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- CRISPR
- RNA-based delivery systems (mRNA)
- Nanoparticle-based gene transport
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2020 - 2033
- In vivo gene delivery
- Ex vivo modification
- Physical methods
- Chemical methods
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical & biotech companies
- Academic & research institutes
- Contract manufacturing organizations (CMOs)
- Hospitals
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Gene Transfer Technologies Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Gene Transfer Technologies Market Snippet by Type
2.1.2. Gene Transfer Technologies Market Snippet by Application
2.1.3. Gene Transfer Technologies Market Snippet by Technology
2.1.4. Gene Transfer Technologies Market Snippet by Delivery Method
2.1.5. Gene Transfer Technologies Market Snippet by End User
2.1.6. Gene Transfer Technologies Market Snippet by Country
2.1.7. Gene Transfer Technologies Market Snippet by Region
2.2. Competitive Insights
3. Gene Transfer Technologies Key Market Trends
3.1. Gene Transfer Technologies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Gene Transfer Technologies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Gene Transfer Technologies Market Opportunities
3.4. Gene Transfer Technologies Market Future Trends
4. Gene Transfer Technologies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Gene Transfer Technologies Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Gene Transfer Technologies Market Landscape
6.1. Gene Transfer Technologies Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Gene Transfer Technologies Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Viral vectors
7.1.3. Non-viral vectors
7.1.4. Reagents, kits, and assays
7.1.5. Instruments
8. Gene Transfer Technologies Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Gene therapy
8.1.3. Cell therapy
8.1.4. Vaccine development
8.1.5. Research & drug discovery
9. Gene Transfer Technologies Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. CRISPR
9.1.3. RNA-based delivery systems (mRNA)
9.1.4. Nanoparticle-based gene transport
9.1.5. Others
10. Gene Transfer Technologies Market – By Delivery Method
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. In vivo gene delivery
10.1.3. Ex vivo modification
10.1.4. Physical methods
10.1.5. Chemical methods
11. Gene Transfer Technologies Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Biopharmaceutical & biotech companies
11.1.3. Academic & research institutes
11.1.4. Contract manufacturing organizations (CMOs)
11.1.5. Hospitals
11.1.6. Others
12. Gene Transfer Technologies Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Gene Transfer Technologies Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Gene Transfer Technologies Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Gene Transfer Technologies Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Gene Transfer Technologies Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Gene Transfer Technologies Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Method, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Gene Transfer Technologies Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Novartis
13.2.2. Roche (Spark Therapeutics)
13.2.3. Pfizer
13.2.4. Bristol Myers Squibb
13.2.5. Sanofi
13.2.6. Gilead Sciences (Kite Pharma)
13.2.7. Bluebird Bio
13.2.8. Sarepta Therapeutics
13.2.9. CRISPR Therapeutics
13.2.10. Editas Medicine
13.2.11. Intellia Therapeutics
13.2.12. Regenxbio
13.2.13. Orchard Therapeutics
13.2.14. BioMarin Pharmaceutical
13.2.15. UniQure
13.2.16. Sangamo Therapeutics
13.2.17. Voyager Therapeutics
13.2.18. Vertex Pharmaceuticals
13.2.19. Alnylam Pharmaceuticals
13.2.20. Amgen
13.2.21. Takeda Pharmaceutical
13.2.22. Lonza Group
13.2.23. Thermo Fisher Scientific
13.2.24. Danaher Corporation (Cytiva)
13.2.25. Merck KGaA
13.2.26. Sartorius AG
13.2.27. Charles River Laboratories
13.2.28. Qiagen
13.2.29. Agilent Technologies
13.2.30. Catalent
13.2.31. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis
- Roche (Spark Therapeutics)
- Pfizer
- Bristol Myers Squibb
- Sanofi
- Gilead Sciences (Kite Pharma)
- Bluebird Bio
- Sarepta Therapeutics
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Regenxbio
- Orchard Therapeutics
- BioMarin Pharmaceutical
- UniQure
- Sangamo Therapeutics
- Voyager Therapeutics
- Vertex Pharmaceuticals
- Alnylam Pharmaceuticals
- Amgen
- Takeda Pharmaceutical
- Lonza Group
- Thermo Fisher Scientific
- Danaher Corporation (Cytiva)
- Merck KGaA
- Sartorius AG
- Charles River Laboratories
- Qiagen
- Agilent Technologies
- Catalent
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Viral vectors
- Non-viral vectors
- Reagents, kits, and assays
- Instruments
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Gene therapy
- Cell therapy
- Vaccine development
- Research & drug discovery
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- CRISPR
- RNA-based delivery systems (mRNA)
- Nanoparticle-based gene transport
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2020 - 2033
- In vivo gene delivery
- Ex vivo modification
- Physical methods
- Chemical methods
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical & biotech companies
- Academic & research institutes
- Contract manufacturing organizations (CMOs)
- Hospitals
- Others
GLOBAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
